Keyphrases
Acetylcholinesterase
11%
Alcoholic Extract
11%
AMPA Receptor (AMPAR)
11%
Binding Protein
11%
Butea Superba
100%
CaMKII
11%
Choline Acetyltransferase (ChAT)
11%
Cholinergic System
11%
Cognition Dysfunction
11%
Cognitive Deficits
100%
Cognitive Function
11%
Cognitive Performance
11%
Cyclic Adenosine Monophosphate (cAMP)
11%
Depressive-like Behavior
33%
Emotional Deficits
100%
Hippocampus
11%
Imipramine
33%
In Vitro Activation
11%
Modified Y-maze
11%
Molecular Mechanism
11%
N-methyl-D-aspartate Receptor (NMDAR)
11%
Neurochemicals
11%
Novel Object Recognition
11%
Olfactory Bulbectomized Mice
100%
Phosphorylation
11%
Responsive Element
11%
Signaling Molecules
11%
Spatial Cognitive
11%
Synaptic Plasticity-related Signaling
22%
Tacrine
44%
Tail Suspension Test
11%
Y-maze Test
11%
Neuroscience
Acetylcholinesterase
25%
AMPA Receptor
25%
Behavior (Neuroscience)
75%
Calmodulin
25%
Choline Acetyltransferase
25%
Cholinergic
25%
Cognitive Disorders
25%
Cognitive Function
25%
Cyclic AMP Responsive Element Binding Protein
25%
Hippocampus
25%
Imipramine
75%
Kinase
25%
NMDA Receptor
25%
Synaptic Plasticity
50%
Tacrine
100%
Tail Suspension Test
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholinesterase
11%
AMPA Receptor
11%
Butea
100%
Calmodulin
11%
Choline Acetyltransferase
11%
Cholinergic Receptor Stimulating Agent
11%
Cognitive Defect
11%
Cyclic AMP Responsive Element Binding Protein
11%
Imipramine
33%
N Methyl Dextro Aspartic Acid Receptor
11%
Phosphotransferase
11%
Tacrine
44%